Загрузка...
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
BACKGROUND AND OBJECTIVES: Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia, requires 21 days of oral aripiprazole supplementation upon initiation (21-day initiation regimen). An alternative 1-day initiation regimen utilizing a nano-crystalline mi...
Сохранить в:
| Опубликовано в: : | Eur J Drug Metab Pharmacokinet |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6060990/ https://ncbi.nlm.nih.gov/pubmed/29943125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-018-0488-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|